CHI3L1 and Alzheimer disease: Increased CSF YKL-40 levels have been reported in cognitively healthy APOE-ε4 carriers, amnestic mild cognitive impairment (aMCI), and AD patients [14] and also in frontotemporal dementia [18] and amyotrophic lateral sclerosis [19].